Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources
News and Community
About us

Lupin Australia Pty Limited

Regulatory activities for this sponsor.

Loading...

Cancellation by sponsor (292) Cancellation by sponsor (292)
ARTG (241) ARTG (241)
Prescription medicine registration (22)

2025 (9) 2025 (9)
2024 (49) 2024 (49)
2023 (47) 2023 (47)
2022 (222) 2022 (222)
2021 (8) 2021 (8)
2020 (33) 2020 (33)
2019 (21) 2019 (21)
2018 (32) 2018 (32)
2017 (11) 2017 (11)
2016 (10) 2016 (10)
2014 (27) 2014 (27)
2013 (17) 2013 (17)
2012 (2) 2012 (2)
2011 (16) 2011 (16)
2010 (19) 2010 (19)
2009 (1) 2009 (1)
2008 (21) 2008 (21)
2007 (5) 2007 (5)
2001 (1) 2001 (1)
1991 (4) 1991 (4)

Search

Sponsor content

555 result(s) found, displaying 161 to 170

CELECOXIB BW celecoxib 200 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
CELECOXIB GENERICHEALTH celecoxib 100 mg capsules blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
MEMANTIPIN memantine hydrochloride 20mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
MEMANTIPIN memantine hydrochloride 15mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
MEMANTIPIN memantine hydrochloride 10mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
MEMANTIPIN memantine hydrochloride 5mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
MEMANTINE-LAX memantine hydrochloride 20mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
MEMANTINE-LAX memantine hydrochloride 15mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
MEMANTINE-LAX memantine hydrochloride 10mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
MEMANTINE-LAX memantine hydrochloride 5mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2022

Cancellation by sponsor

Requested by Lupin Australia Pty Limited

Pages

First page
Previous page
…
Page 13
Page 14
Page 15
Page 16
Current page 17
Page 18
Page 19
Page 20
Page 21
…
Next page
Last page

Is there anything wrong with this page?

Help us improve this page

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control - external site
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook - external site
(formerly Twitter) - external site
Youtube - external site
Instagram - external site
LinkedIn - external site

Help us improve

We are always looking for ways to improve our website.

Provide feedback - external site

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

Lupin Australia Pty Limited

Type

Date

Help us improve this page